← All trials
NCT06261840
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2024
- Primary completion
- May 1, 2029
- Completion date
- Jul 31, 2029
- First posted
- Feb 15, 2024
- Last posted
- Feb 15, 2024
- Enrollment
- 1200
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Tulane UniversityLead sponsor
- University of Alabama, BirminghamCollaborator
- Tulane UniversityOfficial
- Louisiana State UniversityCollaborator
- Tulane UniversitySponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.